Early research (Phase 1)Looking for participantsNCT07501117What this trial is testingNeoadjuvant Immunotherapy for Patients With High-risk Eye MelanomaWho this might be right forUveal Melanoma Inge Marie Svane 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698019What this trial is testingCompare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk MelanomaWho this might be right forAcral Lentiginous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+1 more National Cancer Institute (NCI) 313
Testing effectiveness (Phase 2)Study completedNCT00928902What this trial is testingTrial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk MelanomaWho this might be right forMelanoma University of Virginia 41
Large-scale testing (Phase 3)Study completedNCT01667419What this trial is testingVemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant MelanomaWho this might be right forMelanoma Hoffmann-La Roche 498
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121What this trial is testingScreening for Brain MetastasesWho this might be right forLung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic University of Zurich 180
Not applicableStudy completedNCT03693378What this trial is testingIMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk GroupsWho this might be right forPancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome Immunovia, Inc. 1,349
Testing effectiveness (Phase 2)WithdrawnNCT03327064What this trial is testingA Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin CancerWho this might be right forNon-melanoma Skin Cancer University of Alabama at Birmingham
Not applicableStudy completedNCT00723710What this trial is testingEffect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)Who this might be right forMelanoma Merck Sharp & Dohme LLC 299
Large-scale testing (Phase 3)WithdrawnNCT01861938What this trial is testingModified Melanoma Vaccine for High Risk or Low Residual Disease PatientsWho this might be right forHigh Risk HLA-A2+ MelanomaMetastatic Disease Hadassah Medical Organization
Testing effectiveness (Phase 2)Active Not RecruitingNCT06157099What this trial is testingAtorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA MelanomaWho this might be right forPathologic Stage IIIA Cutaneous Melanoma AJCC v8Pathologic Stage IIA Cutaneous Melanoma AJCC v8Pathologic Stage IIB Cutaneous Melanoma AJCC v8 OHSU Knight Cancer Institute 150
Not applicableStudy completedNCT02213471What this trial is testingPatient Preference for Biopsy NotificationWho this might be right forElevated Risk for Melanoma Maria Wei 301
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808515What this trial is testingA Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)Who this might be right forLocally Advanced Basal Cell Carcinoma Regeneron Pharmaceuticals 135
Large-scale testing (Phase 3)Active Not RecruitingNCT05608291What this trial is testingA Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With SurgeryWho this might be right forMelanoma Regeneron Pharmaceuticals 1,564
Not applicableStudy completedNCT02206360What this trial is testingPancreatic Cancer Early Detection ProgramWho this might be right forPancreatic CancerPancreas CancerPancreatic Adenocarcinoma+8 more White Plains Hospital 181
Not applicableStudy completedNCT02074605What this trial is testingCognitive Effects of Interferon in Patients With MelanomaWho this might be right forMelanoma University of Arizona 36
Testing effectiveness (Phase 2)Study completedNCT01189383What this trial is testingIL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV MelanomaWho this might be right forMalignant Melanoma Stage IIIMalignant Melanoma Stage IV Baylor Research Institute 20
Large-scale testing (Phase 3)Study completedNCT02388906What this trial is testingEfficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 906
Testing effectiveness (Phase 2)Looking for participantsNCT01898039What this trial is testingModified Vaccine for High Risk or Low Residual Melanoma PatientsWho this might be right forMalignant Melanoma Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Study completedNCT03554083What this trial is testingVemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+3 more Mayo Clinic 64
Testing effectiveness (Phase 2)Study completedNCT02334735What this trial is testingA Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma RecurrenceWho this might be right forMelanoma Nina Bhardwaj 36